A month has gone by since the last earnings report for VIVUS, Inc. VVUS. Shares have lost about 19.8% in that time frame, underperforming the market. Will the recent negative trend continue leading up to the stock's next earnings …

One such company that looks well positioned for a solid gain, but has been overlooked by investors lately, is VIVUS Inc. (NASDAQ: VVUS). This Medical – Biomedical/Genetics stock has actually seen loss estimates narrow over the past …

WASHINGTON, May 5 (Reuters) - Pharmaceutical company Vivus Inc (VVUS.O) on Monday filed to sell up to $150 million in common stock. Vivus said in a filing with the U.S. Securities and Exchange Commission that it plans to use the …

One such company that looks well positioned for a solid gain, but has been overlooked by investors lately, is VIVUS Inc. (VVUS). This Medical – Biomedical/Genetics stock has actually seen loss estimates narrow over the past month for …